Literature DB >> 17875576

Neonatal nasal intermittent positive pressure ventilation: a survey of practice in England.

L S Owen1, C J Morley, P G Davis.   

Abstract

BACKGROUND: Less invasive techniques of respiratory support are increasingly popular.
OBJECTIVE: To determine how widespread the use of neonatal nasal intermittent positive airway pressure (NIPPV) has become and describe the range of practice used in NIPPV in England.
METHODS: 95 English Neonatal intensive care units were asked to provide information about NIPPV devices, interfaces, indications, guidelines, use of synchronisation, complications, settings and weaning.
RESULTS: 91 (96%) units replied. NIPPV was used by 44/91 (48%) units; few complications were seen. 34/44 (77%) used a synchronising device, 35/44 (80%) used NIPPV for "rescuing" babies for whom continuous positive airway pressure failed-59% routinely after extubation and 16% as a first-line treatment. A wide range of pressure and rate settings were used.
CONCLUSIONS: In England, NIPPV is commonly used, with considerable variability in the techniques applied. The wide range of clinical approaches highlights the paucity of evidence available. More evidence is needed to establish best practice.

Entities:  

Mesh:

Year:  2007        PMID: 17875576     DOI: 10.1136/adc.2007.118109

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  14 in total

1.  Noninvasive high frequency oscillatory ventilation through nasal prongs: bench evaluation of efficacy and mechanics.

Authors:  Daniele De Luca; Virgilio P Carnielli; Giorgio Conti; Marco Piastra
Journal:  Intensive Care Med       Date:  2010-09-21       Impact factor: 17.440

Review 2.  Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation.

Authors:  Brigitte Lemyre; Peter G Davis; Antonio G De Paoli; Haresh Kirpalani
Journal:  Cochrane Database Syst Rev       Date:  2017-02-01

3.  Neonatal nasal intermittent positive pressure ventilation efficacy and lung pressure transmission.

Authors:  A Mukerji; J Belik
Journal:  J Perinatol       Date:  2015-06-04       Impact factor: 2.521

4.  Factors affecting nasal intermittent positive pressure ventilation failure and impact on bronchopulmonary dysplasia in neonates.

Authors:  P Mehta; J Berger; E Bucholz; V Bhandari
Journal:  J Perinatol       Date:  2014-05-29       Impact factor: 2.521

5.  Non-invasive high-frequency ventilation versus bi-phasic continuous positive airway pressure (BP-CPAP) following CPAP failure in infants <1250 g: a pilot randomized controlled trial.

Authors:  A Mukerji; K Sarmiento; B Lee; K Hassall; V Shah
Journal:  J Perinatol       Date:  2016-09-29       Impact factor: 2.521

6.  Work of breathing during HHHFNC and synchronised NIPPV following extubation.

Authors:  Elinor Charles; Katie A Hunt; Gerrard F Rafferty; Janet L Peacock; Anne Greenough
Journal:  Eur J Pediatr       Date:  2018-10-30       Impact factor: 3.183

Review 7.  Non-invasive Ventilation in Premature Infants: Based on Evidence or Habit.

Authors:  Shalabh Garg; Sunil Sinha
Journal:  J Clin Neonatol       Date:  2013-10

8.  Initial Treatment of Respiratory Distress Syndrome with Nasal Intermittent Mandatory Ventilation versus Nasal Continuous Positive Airway Pressure: A Randomized Controlled Trial.

Authors:  Amir-Mohammad Armanian; Zohreh Badiee; Ghobad Heidari; Awat Feizi; Nima Salehimehr
Journal:  Int J Prev Med       Date:  2014-12

9.  Economic and health consequences of non-invasive respiratory support in newborn infants: a difference-in-difference analysis using data from the Norwegian patient registry.

Authors:  Inger Cathrine Kann; Anne Lee Solevåg
Journal:  BMC Health Serv Res       Date:  2014-11-01       Impact factor: 2.655

10.  Analysis and comparison of the effects of N-BiPAP and Bubble-CPAP in treatment of preterm newborns with the weight of below 1500 grams affiliated with respiratory distress syndrome: A randomised clinical trial.

Authors:  Alireza Sadeghnia; Behzad Barekateyn; Zohre Badiei; Seyyed Mohsen Hosseini
Journal:  Adv Biomed Res       Date:  2016-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.